XML 17 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities:      
Net Loss $ (3,215,054) $ (1,240,590)  
Adjustment to reconcile net loss to net cash used in operating activities:      
Changes in fair value of derivative liability 338,229  
Depreciation and amortization 37,379 37,857  
Recovery from credit losses (868) (17,120)  
Other non-cash expenses relating to ELOC Facility 1,092,222  
Stock based compensation 394,326 330,825  
Changes in operating assets and liabilities:      
Accounts receivable (479,485) (194,922)  
Inventory 25,209 (57,684)  
Tax refund receivable 6,377  
Prepaid insurance (199,491)  
Other current assets (235,839) (52,785)  
Right of use liability, net 276,884 4,770  
Security Deposits and other assets 3,650  
Accounts payable and accrued expenses 86,839 (97,639)  
Deferred revenue (89,052)  
Deferred tax liability 4,106  
Corporate taxes payable 278  
Net cash used in operating activities (1,679,880) (1,561,698)  
Cash flows used in investing activities      
Purchase of property and equipment (35,312) (15,000)  
Net cash used in investing activities (35,312) (15,000)  
Cash flows provided by financing activities:      
Related party loans 18,669  
Proceeds from IPO and overallotment, net 4,680,013  
Proceeds from offering of ELOC shares 1,000,000  
Net cash provided by financing activities 1,000,000 4,698,682  
Increase (decrease) in cash and cash equivalents (715,192) 3,121,984  
Cash and cash equivalents at beginning of period 2,130,758 2,097,945 $ 2,097,945
Cash and cash equivalents at end of period 1,415,566 5,219,929 $ 2,130,758
Supplemental disclosures of cash flow information:      
Cash paid for interest 63  
Lease incentives reimbursement 280,115  
Supplemental Schedule of Non-Cash Operating, Investing, and Financing Activities:      
Issuance of common stock for ELOC-related consideration and expenses 1,092,222  
Right of use assets acquired and operating lease liabilities recognized for new lease arrangement 38,737  
Restricted stock unit awards vesting 18  
Fair value of Stock Warrants issued at IPO 144,358  
Deferred offering costs charged to additional paid-in-capital $ 136,025